Vaxtex Cotfab Limited — Others, 28-11-2024: Corporate Insolvency Resolution Process

Vaxtex Cotfab Limited has announced a board meeting focused on the outcome of its Eighth Meeting of the Committee of Creditors (CoC) concerning its ongoing Corporate Insolvency Resolution Process (CIRP). The CoC approved the withdrawal of a prior application against the company with 93.89% support, as well as the CIRP cost with 68.12% approval. This development could signify a positive shift towards stabilizing the company's operational status, fostering a more favorable environment for potential creditors and investors. A compliant approach may enhance investor confidence, reflecting both a reduction in immediate financial risk and prospects for future growth.